文献速递主动脉疾病

基于30天计算机断层血管造影的个体化随访在血管内动脉瘤修复术后的可靠性与安全性

Reliability and Safety of Individualized Follow-up Based on the 30-day Computed Tomography Angiogram after Endovascular Aneurysm Repair.
PubMed 文献 · Ann Vasc Surg · 2022-04-22

该回顾性研究分析了2005至2013年间348例择期标准血管内动脉瘤修复术(EVAR)患者,按欧洲血管外科学会(ESVS)基于30天影像的随访方案进行回顾性拟合。结果显示,30天无内漏且封堵充分的低风险患者中,11.6%在5年内仍需再干预,30天计算机断层血管造影(CTA)预测5年内显著并发症的敏感度为34.9%、特异度为83.3%。作者认为遵循该ESVS方案会遗漏重大危及生命的并发症。

要点

  • 30天CTA无内漏且封堵充分(≥1 cm)的患者中,11.6%(n=32)在5年内因移植物相关并发症需再干预。
  • 遵循ESVS建议方案会遗漏需治疗的并发症,包括1A型内漏7例、1B型10例、2型7例、移植物移位2例、血栓形成10例、扭结1例和腹主动脉瘤破裂6例。
  • 30天CTA预测5年内显著并发症的敏感度为34.9%(95%CI 21.01-50.93%),特异度为83.3%(95%CI 78.57-87.41%)。

核心结论

  • 基于本研究结果,遵循ESVS随访方案示例会遗漏重大危及生命的并发症。
  • 即使术后1个月首次CTA结果无并发症,显著支架移植物失败仍会在5年内发生。

研究设计与样本

  • 回顾性分析2005至2013年间348例择期标准EVAR治疗的腹主动脉瘤(AAA)患者。
  • 所有患者每年随访,并基于影像学表现回顾性拟合至ESVS随访方案。

主要发现

  • 平均随访74个月(标准误2.1;范围0-165个月),30天死亡率为1.1%(n=4)。
  • 存活超过30天的患者中,98.8%(n=340)有可用影像数据。
  • 1个月控制检查时,79.3%(n=276)的患者无内漏且封堵充分(≥1 cm)。
  • 在风险最低的患者中,11.6%(n=32)在随后5年内因移植物相关并发症需再干预。
  • 遵循建议方案会遗漏的需治疗并发症包括1A型内漏(n=7)、1B型(n=10)、2型(n=7)、移植物移位(n=2)、血栓形成(n=10)、扭结(n=1)和腹主动脉瘤破裂(n=6)。

临床怎么用

  • 作者认为,基于本研究结果,遵循ESVS随访方案示例会遗漏重大危及生命的并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most patients undergo uneventful surveillance after endovascular aneurysm repair (EVAR), and therefore, unmodified surveillance protocols are ineffective. An example of a modified follow-up protocol was introduced by the European Society for Vascular Surgery (ESVS) in January 2019. One feature of this protocol is that for the patients with adequate sealing and without any detectable endoleak at 30 days, the next scheduled follow-up could be at 5 years. The purpose of this study was to analyze retrospectively the applicability of this protocol. METHODS: Between 2005 and 2013, 348 patients were treated electively for abdominal aortic aneurysm (AAA) with a standard EVAR. All patients were annually followed and they were retrospectively fitted into the ESVS follow-up protocol based on imaging findings. RESULTS: The mean follow-up was 74 months (standard error 2.1; range, 0-165 months). Thirty-day mortality was 1.1% (n = 4). Imaging data for those surviving the first 30 days were available for 98.8% (n = 340) subjects. At a 1-month control examination, 79.3% (n = 276) of the patients had no detectable endoleak and sealing was adequate (≥1 cm). Of those patients, with the lowest risk, 11.6% (n = 32) required reintervention for graft-related complication during the next 5 years. In all, complications requiring treatment that would have been missed by following the suggested protocol included type 1A endoleak (n = 7), type 1B (n = 10), type 2 (n = 7), migration (n = 2), thrombosis (n = 10), kinking (n = 1), and ruptured AAA (n = 6). The sensitivity of 30-day computed tomography angiogram was 34.9% (95% confidence interval 21.01-50.93%) and specificity 83.3% (95% confidence interval 78.57-87.41%) for finding significant complications during first 5 years. CONCLUSIONS: Based on our findings, by following the example ESVS follow-up protocol, we would have missed major life-threatening complications. Significant stent-graft failures occur during the first 5 years, even for those with noncomplicated post-EVAR findings in the first computed tomography angiogram at 1 month.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Väärämäki S, Uurto I, Hahl T, et al. Reliability and Safety of Individualized Follow-up Based on the 30-day Computed Tomography Angiogram after Endovascular Aneurysm Repair. Ann Vasc Surg. 2022. PMID: 35461997. doi:10.1016/j.avsg.2022.04.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。